This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
This article presents geochemical characteristics of the alkaline rocks of Rio Bonito intrusive complex, State of Rio de Janeiro, Brazil, which is constituted mainly by nepheline syenite. The fractional crystallisation of this magma decreases K2O/(Na2O + K2O) and increases (Na + K)/Al. The TiO2, Fe2O3*, MgO, CaO, and P2O5 contents indicate fractionation of titanite, ilmenite, and clinopyroxene or amphibole. The total rare earth elements (REEs) are high, and the REE pattern is linear with negative gradient. The nepheline syenite aplite has low REEs, concave REE pattern, and positive Eu anomaly. The ultrabasic and basic mela-nepheline syenite samples have total REEs and light REEs higher than the felsic alkaline rocks. Therefore, the nepheline syenite magma is not derived directly from the alkaline ultrabasic magma. Laser-spot step‑heating 40Ar/39Ar ages for biotite and amphibole are 65.03 ± 0.70 and 65.03 ± 0.46. U-Pb ages LA-ICP-MS for two samples are 65.49 ± 0.30 and 65.18 ± 0.30. Values of εHf are negative for both samples, indicating an important crustal component in the evolution of Rio Bonito.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.